Infant Bacterial Therapeutics AB (publ) (STO:IBT.B)
Sweden flag Sweden · Delayed Price · Currency is SEK
66.80
+1.20 (1.83%)
Jul 24, 2026, 5:29 PM CET

STO:IBT.B Balance Sheet

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
131.93144.01223.39329.06335.84386.75
Cash & Short-Term Investments
131.93144.01223.39329.06335.84386.75
Cash Growth
-31.20%-35.53%-32.11%-2.02%-13.16%-8.66%
Other Receivables
1.582.7942.971.471.2
Total Trade Receivables
1.582.7942.971.471.2
Other Current Assets
1.676.813.229.531.729.14
Total Current Assets
135.18153.61230.61341.56339.03397.09
Other Intangible Assets
7.878.078.899.710.5211.33
Long-Term Investments
0.070.070.070.070.070.05
Total Assets
143.11161.75239.57351.33349.62408.48
Accounts Payable
46.4343.8646.9930.078.754.8
Accrued Expenses
13.7212.1721.8915.338.677.65
Other Current Liabilities
0.390.390.420.780.50.78
Total Current Liabilities
60.5456.4269.346.1817.9113.22
Total Liabilities
60.5456.4269.346.1817.9113.22
Common Stock
3.673.673.673.673.063.06
Additional Paid-in Capital
768.84768.84768.84766.83670.93669.02
Retained Earnings
-689.94-667.18-602.25-465.35-342.28-276.83
Shareholders' Equity
82.58105.33170.26305.15331.71395.25
Total Liabilities & Equity
143.11161.75239.57351.33349.62408.48
Net Cash (Debt)
131.93144.01223.39329.06335.84386.75
Net Cash Growth
-8.39%-35.53%-32.11%-2.02%-13.16%-8.66%
Net Cash Per Share
9.7910.6918.0726.6129.9234.45
Book Value
82.58105.33170.26305.15331.71395.25
Book Value Per Share
6.137.8213.7724.6829.5535.21
Tangible Book Value
74.7197.26161.38295.45321.19383.92
Tangible Book Value Per Share
5.557.2213.0523.8928.6134.20